Prostate cancer decisions — 2022

The Board has granted service connection for the cause of the Veteran's death due to metastatic carcinoid tumor and prostate cancer, which are presumed related to his military service at Udorn RTAFB in Thailand.

The Board has granted the appellant's claims for service connection for prostate cancer, hearing loss, and tinnitus. The character of discharge from service is not considered a bar to VA benefits.

The Board has determined that new and material evidence has been received to reopen the previously denied claim of service connection for prostate cancer/prostate condition. The Veteran's exposure to contaminated water at Camp Lejeune is presumed, but further examination is needed to determine if his current prostate cancer is related.,Service connection for colon cancer is also granted based on presumed exposure to contaminated water at Camp Lejeune. However, a VA examination is required to assess the relationship between the Veteran's current condition and service.

The Veteran's appeals for service connection for non-Hodgkin's lymphoma and prostate cancer have been dismissed due to the death of the Veteran.

The Board has decided to remand the case due to insufficient evidence regarding whether the Veteran's prostate cancer is related to his service, including potential environmental exposures. The VA will need to obtain additional medical opinions and possibly more records.

The Board has remanded the claims for service connection for thyroid cancer, prostate cancer, and brain tumor due to potential exposure to contaminated water at Camp LeJeune. The Veteran's claim is being reopened based on new evidence.

The Veteran's service connection claim for prostate cancer is granted due to his exposure to herbicide agents during service. The claims for sleep apnea, COPD, sarcoidosis, and hypertension are remanded for further development.

The Veteran's claim for service connection for bilateral hearing loss was reopened and granted. His prostate cancer residuals were also granted a rating of 60 percent, effective from March 1, 2019.

Service connection has been granted for prostate cancer and diabetes mellitus type II, both presumed to be due to herbicide agent exposure during service. Service connection is also being remanded for hypertension as secondary to service-connected diabetes mellitus type II.,The Veteran's hypertension was not directly related to his active duty service but may have been aggravated by his service-connected diabetes mellitus type II.

The Board has granted service connection for the cause of the Veteran's death due to prostate cancer, which is presumed to be related to herbicide exposure in Thailand. The decision also grants service connection for prostate cancer itself based on this presumption.

The Veteran's TDIU claim is granted, but his diabetes mellitus rating remains remanded for further action.

The Board has granted service connection for asbestosis, restrictive/obstructive lung disease, and prostate cancer. The appeal regarding bladder cancer and cerebrovascular accident (CVA) is remanded.

The Board has determined that the issue of an increased rating for prostate cancer in excess of 40 percent is remanded due to inadequate examination and development needs. The propriety of the reduction in the rating for prostate cancer from 100 percent to 40 percent, effective July 1, 2013, and the SMC claim related to housebound status are not addressed as they were opted into the modernized review system.

The Veteran's appeal for a higher rating of prostate cancer and erectile dysfunction was denied. The Board found that there is no evidence of reoccurrence or metastasis, and the Veteran does not need to change absorbent materials more than twice per day for stress incontinence.

The Board has remanded the Veteran's claims for service connection due to conflicting evidence and need for further development. The claims include prostate cancer, hyperthyroidism, erectile dysfunction (secondary to prostate cancer), TBI, and depression.

The Board denied DIC benefits based on service connection for the cause of the Veteran's death, finding that fatigue from his prostate cancer treatment did not substantially or materially contribute to his death.

The Veteran's prostate cancer was in remission prior to October 19, 2016. From that date forward, his prostate cancer has been active and warrants a 100% rating.,Service connection for gynecomastia is granted as secondary to the service-connected prostate cancer.

The Board denied service connection for diabetes mellitus type 2 and prostate cancer associated with herbicide exposure, finding no in-service exposure to such agents.

The Veteran's claim for service connection for Other Traumatic Stressor Disorder with Anhedonia is granted. The claims for cardiovascular, gastrointestinal or genitourinary disabilities, and skin disability are remanded.

The Veteran's appeal is remanded for further development regarding his PTSD and prostate cancer claims.